HAE Haemonetics Corp

Haemonetics Corp is a health care company. It provides products enabling the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.

$77.70  +1.84 (2.43%)
As of 10/04/2022 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  02/21/2001
Outstanding shares:  51,316,543
Average volume:  404,246
Market cap:   $3,798,963,678
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2401195
Valuation   (See tab for details)
PE ratio:   89.75
PB ratio:   5.17
PS ratio:   3.83
Return on equity:   2.69%
Net income %:   2.03%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy